# Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients

> **NCT01331915** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 23 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** Theravac

## Key facts

- **NCT ID:** NCT01331915
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2012-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331915, "Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01331915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*